Correlation Between TC BioPharm and Neuroone Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both TC BioPharm and Neuroone Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining TC BioPharm and Neuroone Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between TC BioPharm plc and Neuroone Medical Technologies, you can compare the effects of market volatilities on TC BioPharm and Neuroone Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in TC BioPharm with a short position of Neuroone Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of TC BioPharm and Neuroone Medical.

Diversification Opportunities for TC BioPharm and Neuroone Medical

0.3
  Correlation Coefficient

Weak diversification

The 3 months correlation between TCBPW and Neuroone is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding TC BioPharm plc and Neuroone Medical Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neuroone Medical Tec and TC BioPharm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on TC BioPharm plc are associated (or correlated) with Neuroone Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neuroone Medical Tec has no effect on the direction of TC BioPharm i.e., TC BioPharm and Neuroone Medical go up and down completely randomly.

Pair Corralation between TC BioPharm and Neuroone Medical

Assuming the 90 days horizon TC BioPharm plc is expected to generate 19.24 times more return on investment than Neuroone Medical. However, TC BioPharm is 19.24 times more volatile than Neuroone Medical Technologies. It trades about 0.12 of its potential returns per unit of risk. Neuroone Medical Technologies is currently generating about 0.02 per unit of risk. If you would invest  1.12  in TC BioPharm plc on October 22, 2024 and sell it today you would earn a total of  0.62  from holding TC BioPharm plc or generate 55.36% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy89.91%
ValuesDaily Returns

TC BioPharm plc  vs.  Neuroone Medical Technologies

 Performance 
       Timeline  
TC BioPharm plc 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in TC BioPharm plc are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, TC BioPharm showed solid returns over the last few months and may actually be approaching a breakup point.
Neuroone Medical Tec 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Neuroone Medical Technologies are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating basic indicators, Neuroone Medical exhibited solid returns over the last few months and may actually be approaching a breakup point.

TC BioPharm and Neuroone Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with TC BioPharm and Neuroone Medical

The main advantage of trading using opposite TC BioPharm and Neuroone Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if TC BioPharm position performs unexpectedly, Neuroone Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neuroone Medical will offset losses from the drop in Neuroone Medical's long position.
The idea behind TC BioPharm plc and Neuroone Medical Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume